Introduction {#sec1}
============

Microtubules (MTs) are cytoskeletal components that serve important roles in various cellular processes, such as intracellular material transportation, cellular support, and cell division.^[@ref1]−[@ref3]^ MTs are hollow tubular structures consisting of tubulin heterodimers and are constantly extending (polymerizing) and contracting (depolymerizing) in cells. The dynamics of polymerization/depolymerization by MTs are essential to maintain cellular activities, including the cell cycle.^[@ref1]−[@ref3]^ Directional transport of intracellular cargos on MTs by motor proteins (kinesin and dynein) is also important in cells, which have been widely utilized to construct MT-based active materials.^[@ref2],[@ref4]−[@ref9]^ Because of the importance of MTs, various methodologies have been developed to monitor MTs in living cells without chemical fixation to understand and modulate the dynamics of MTs.^[@ref10]−[@ref12]^ Expression of fluorescent protein-fused tubulin is a general method to monitor MTs in living cells.^[@ref11]^ However, the low efficiency of transfection and low expression levels may be problematic. Alternatively, small-molecule fluorescent probes have been developed by using MT-binding drugs as scaffolds.^[@ref12]^ Taxol and colchicine are well-known MT-targeted drugs that inhibit depolymerization and polymerization of MTs, respectively.^[@ref13]^ By conjugating fluorophores to taxol^[@ref14]−[@ref22]^ and colchicine^[@ref23]^ scaffolds, intracellular imaging of MTs has been achieved with high efficiency and high resolution. These drug-based probes are useful because of their permeability to cells and high selectivity for MTs. However, these drug scaffolds have several problems, such as low water solubility and complex structures with limited numbers of reactive groups.^[@ref14]−[@ref16],[@ref18],[@ref20],[@ref22]^ Most importantly, since drug-based probes potentially induce cytotoxicity by affecting the polymerization/depolymerization of MTs, optimization of the probe structures is essential for imaging of MTs with minimal cytotoxicity.^[@ref18],[@ref20],[@ref22]^ Thus, a nondrug MT-targeted molecule will be useful to monitor MTs without disturbing the intracellular dynamics of MTs.

Peptides are attractive candidates for monitoring MTs because of their biocompatibility, sequence-dependent cell permeability, and molecular recognition capability.^[@ref24]−[@ref28]^ In fact, various MT-binding peptides have been developed but the purpose was construction of MT-targeted drugs, and not live-cell imaging of MTs.^[@ref29]−[@ref35]^ Ghosh et al. have developed short (4--9-mer) peptides and peptoids for modulation of intracellular dynamics of MTs by promoting or inhibiting polymerization of MTs.^[@ref30]−[@ref35]^ Although binding of some peptides to MTs in fixed cells has been imaged, no obvious fibrous structures of the peptide-bound MTs were observed.^[@ref31],[@ref32]^ This may be due to the low affinity of short peptides for tubulin, as their dissociation constants (*K*~d~) are in the millimolar range.^[@ref31],[@ref32]^ It is anticipated that peptides with high affinity for MTs without disturbing polymerization/depolymerization of MTs are suitable to monitor MTs in living cells.

We previously developed an MT-binding peptide based on an MT-associated protein, Tau ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a).^[@ref36]^ The Tau-derived peptide **TP** (CGGGKKHVPGGGSVQIVYKPVDL) was designed on the basis of a repeat domain of Tau involved in binding to the inner surface of MTs. From our binding analysis in vitro (not in cellulo), **TP** binds to a taxol-binding pocket of tubulin located inside MTs with high affinity (*K*~d~ = 6.0 μM) by preincubation with tubulin and subsequent polymerization of the peptide--tubulin complex. In contrast, **TP** binds to the outer surface of MTs when incubated with preformed MTs. Binding of **TP** does not inhibit the polymerization/depolymerization of MTs in vitro. In addition, **TP** has high water solubility at millimolar concentrations. These properties of **TP** are suitable for an MT-binding motif in living cells. Here, we prepared fluorescently labeled **TP** and analyzed binding to MTs in living cells. We demonstrated that **TP** can bind to intracellular MTs via endocytic uptake and subsequent endosomal escape ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b) without inhibiting polymerization/depolymerization of MTs.

![(a) Tau-derived peptide (**TP**) designed from Tau protein as a binding motif for microtubules (MTs). (b) Schematic representation of cellular uptake of tetramethylrhodamine (TMR)-labeled **TP** (**TP--TMR**) and subsequent binding to MTs.](ao-2019-01089e_0002){#fig1}

Results and Discussion {#sec2}
======================

Red fluorescent tetramethylrhodamine (TMR)-5-maleimide was conjugated to the N-terminal cysteine of **TP** as a fluorophore according to our reported procedure.^[@ref36]^ The TMR-labeled **TP** (**TP--TMR**) and 5(6)-carboxytetramethylrhodamine (TMR--COOH) showed similar fluorescence spectra ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)), indicating that **TP--TMR** can be used for imaging without quenching TMR. Cellular uptake of **TP--TMR** into human hepatoma HepG2 cells was analyzed by confocal laser scanning microscopy (CLSM). Before incubation with **TP--TMR**, the cells were transfected with green fluorescent protein-fused tubulin (tubulin--GFP) using BacMam technology (Thermo Fischer Scientific), which uses baculovirus as a carrier to deliver and express genes in mammalian cells. Upon incubation of 10 μM **TP--TMR** with the cells for 6 h at 37 °C, **TP--TMR** was found to be internalized into the cells and bind to intracellular MTs, observed as clear fibrous structures ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a and [Movie S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_002.mpg)). The fibers in the **TP--TMR** channel were essentially colocalized with the fibers observed in the tubulin--GFP channel ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b,c). Quantitative analysis of the distribution of fluorescent intensity also showed colocalization of **TP--TMR** and tubulin--GFP fiber structures ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}d,e), indicating the binding of **TP--TMR** to intracellular MTs. In particular, binding of **TP--TMR** to MTs at the edges of cells was clearly observed (white arrows in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a), probably because of the high density of MTs at cell edges to exert cellular support and cell migration.^[@ref37],[@ref38]^ Distribution of **TP--TMR**-bound MTs throughout cells can be seen in [Movie S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_002.mpg), which shows cross-sectional scans of cells acquired at different heights. On the other hand, the dotlike structures observed in the **TP--TMR** channel ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a) were not colocalized with tubulin--GFP ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b,c). The dots were expected to be endosomes, as investigated below. Even by using lower concentration of **TP--TMR** and shorter incubation time compared with the above condition (10 μM **TP--TMR**, 6 h incubation), the binding of **TP--TMR** to intracellular MTs was still observed; however, the fluorescence intensity of **TP--TMR** was low ([Figures S2 and S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)). Thus, we used the above condition (10 μM **TP--TMR**, 6 h of incubation) in the following experiments. In contrast with **TP--TMR**, entry of TMR--COOH into HepG2 cells was not observed even after 6 h of incubation ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)), indicating that the **TP** moiety is required for cellular uptake. These results show that **TP--TMR** can penetrate into cells and bind to intracellular MTs. In addition, even after incubation of the cells for 24 h upon uptake of **TP--TMR**, the binding of **TP--TMR** to intracellular MTs was still observed, indicating that **TP--TMR** can be used for long-term imaging of MTs ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)).

![Binding of **TP--TMR** to MTs in HepG2 cells. Channels for (a) **TP--TMR** (red), (b) tubulin--GFP (green), and (c, d) **TP--TMR**, tubulin--GFP, and Hoechst 33342 (cyan) for confocal laser scanning microscopy (CLSM) images. White arrows in image (a) indicate the binding of **TP--TMR** to MTs at cell edges. (e) Distribution of **TP--TMR** and tubulin--GFP was quantified by measuring fluorescence intensity in the lined areas of the expanded image (d). All scale bars are 10 μm. See [Movie S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_002.mpg) for cross-sectional scans of cells acquired at different heights. Tubulin--GFP was expressed in HepG2 cells; then, 10 μM **TP--TMR** was incubated with the cells for 6 h at 37 °C under 5% CO~2~. Cell nuclei were stained with Hoechst 33342.](ao-2019-01089e_0003){#fig2}

The effects of MT-binding drugs taxol and colchicine on the binding of **TP--TMR** to intracellular MTs were evaluated. Even after coincubation of 10 μM **TP--TMR** and 10 μM taxol (a MT-stabilizing agent) with HepG2 cells, fibrous structures were observed in the **TP--TMR** channel ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a). The fibers were essentially colocalized with the fibers in the tubulin--GFP channel ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b,c), indicating the binding of **TP--TMR** to intracellular MTs even in the presence of taxol. We have previously shown that **TP--TMR** has two binding sites in MTs: (1) a taxol-binding pocket of tubulin when incubating **TP--TMR** with tubulin and subsequent polymerization of the peptide--tubulin complex and (2) the outer surface of MTs when incubating **TP--TMR** with preformed MTs.^[@ref36]^ Because coincubation with taxol showed little effect on the fibrous structures in the **TP--TMR** channel ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a), it is possible that **TP--TMR** mainly binds to the outer surface of preformed MTs. When 10 μM **TP--TMR** was incubated with HepG2 cells in the presence of 10 μM colchicine (an MT-destabilizing agent), cell morphology changed to being round and only dotlike structures were observed but no fiber structures were observed in the **TP--TMR** channel ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d). Also, tubulin--GFP was homogeneously distributed in the cytoplasm and did not form fibrous MTs ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}e). These results clearly indicate that the polymerization of MTs was inhibited by colchicine and **TP--TMR**-bound MTs were not formed under the conditions employed. To elucidate whether **TP--TMR**-bound MTs depolymerize/polymerize in cells, **TP--TMR**-treated cells were cooled and heated as depolymerization and polymerization conditions, respectively. The fibrous structures in the **TP--TMR** channel observed before cooling ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}g) disappeared after cooling ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}h), showing the depolymerization of **TP--TMR**-bound MTs. Upon heating the cells, the polymerization occurred to form **TP--TMR**-bound MTs ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}i). Thus, binding of **TP--TMR** exhibits no apparent effects on depolymerization/polymerization of MTs in living cells, indicating that **TP--TMR** may be useful in monitoring MT dynamics.

![Effects of (a--c) taxol and (d--f) colchicine on the binding of **TP--TMR** to MTs. Channels for (a, d) **TP--TMR**, (b, e) tubulin--GFP, and (c, f) **TP--TMR**, tubulin--GFP, and Hoechst 33342 in CLSM images. Tubulin--GFP was expressed in HepG2 cells, then 10 μM **TP--TMR** with 10 μM taxol or 10 μM colchicine was incubated with the cells for 6 h at 37 °C under 5% CO~2~. Cell nuclei were stained by Hoechst 33342. (g--i) Temperature-dependent depolymerization/polymerization of **TP--TMR**-bound MTs in HepG2 cells. CLSM images were acquired (g) immediately, (h) upon cooling at ∼4 °C for 40 min, and (i) upon heating at ∼40 °C for 5 min. White arrows indicate **TP--TMR**-bound MTs. All scale bars are 10 μm.](ao-2019-01089e_0004){#fig3}

The cellular uptake mechanism of **TP--TMR** was elucidated by cooling the cells during uptake to inhibit an energy-dependent uptake process.^[@ref39]^ Uptake of **TP--TMR** in HepG2 cells was significantly inhibited at 4 °C ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)). This result indicates that uptake of **TP--TMR** involves an endocytic pathway. Since dotlike structures along with fibrous structures were observed in the **TP--TMR** channel when incubated at 37 °C ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a), it is possible that **TP--TMR** is partially released from endosomes, distributed in cytoplasm, and then bound to MTs. To investigate this hypothesis, colocalization of **TP--TMR** and a typical endosome marker, fluorescein isothiocyanate-labeled transferrin (FITC--transferrin), was identified.^[@ref40]^ As a result, the dotlike structures in the **TP--TMR** channel were colocalized with FITC--transferrin, whereas the fibrous structures in the **TP--TMR** channel were not observed in the FITC--transferrin channel ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)). Thus, the dotlike structures in the **TP--TMR** channel are attributed to endosomes and partial endosomal escape of **TP--TMR** results in the binding to MTs observed as fibrous structures in the **TP--TMR** channel. When human glioma U251 cells were used instead of HepG2 cells, only dotlike structures were observed but no fiber structures of MTs were observed in the **TP--TMR** channel ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)), indicating that **TP--TMR** was internalized into U251 cells via an endocytic pathway without subsequent endosomal escape.

We checked the bioactivity of **TP--TMR** using the water-soluble tetrazolium salt (WST) assay, a method to measure cell viability by evaluating mitochondrial activity in living cells. **TP--TMR** over a range of 1--20 μM showed no cytotoxicity even after incubation with HepG2 cells for 24 h ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Even after longer incubation time (72 h), **TP--TMR** showed no cytotoxicity ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf)). In contrast, MT-binding drugs taxol and colchicine showed clear cytotoxicity in a concentration-dependent manner ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). The cytotoxicity of taxol and colchicine is due to inhibition of depolymerization and polymerization of MTs, respectively.^[@ref13]^ Thus, **TP--TMR** showed no cytotoxicity because binding of **TP--TMR** to MTs exhibits minimal effects on depolymerization/polymerization of MTs, as described above. These results indicate that **TP** is useful as a scaffold for MT binding for long-term usage without disturbing cellular activity.

![Cytotoxicity of **TP--TMR** against HepG2 cells. HepG2 cells were incubated with 0--20 μM **TP--TMR** (red), taxol (black), or colchicine (blue) for 24 h at 37 °C under 5% CO~2~. Cell viability was evaluated by the WST assay. The error bars represent standard deviation.](ao-2019-01089e_0005){#fig4}

Conclusions {#sec3}
===========

In conclusion, we have demonstrated that a fluorescently labeled Tau-derived peptide, **TP--TMR**, can be successfully used for imaging of MTs in living cells. Binding of **TP--TMR** to MTs showed no apparent effects on polymerization/depolymerization of MTs and no cytotoxicity in contrast with the known MT-binding drugs taxol and colchicine. Thus, **TP--TMR** can be used for imaging of MTs without disturbing cellular activities. Especially, time-lapse imaging of MTs during cell division is important to analyze the functions of MTs in living cells. We also envision that the **TP** scaffold may be applicable for MT-targeted modulation of cellular activities. A notable example is optical modulation of MT dynamics by designing photoswitchable MT-destabilizing agents, enabling control of mitosis and cell death.^[@ref41]^ In such a way, design of **TP** to control the dynamics of MTs is in progress.

Methods {#sec4}
=======

Equipment and Materials {#sec4.1}
-----------------------

**TP--TMR** was prepared as described in our previous work.^[@ref36]^ High-performance liquid chromatography was performed to purify **TP--TMR** using a Shimadzu LC-6AD liquid chromatograph with GL Science Inertsil WP300 C18 columns (20 × 250 mm^2^). Fluorescence measurements were performed using a Jasco FP-8200. Confocal laser scanning microscopy (CLSM) measurement was carried out using a FluoView FV10i (Olympus). The reagents were purchased from Watanabe Chemical Ind., Ltd., Tokyo Chemical Industry Co., Dojindo Laboratories Co., Ltd. and Wako Pure Chemical Industries. All chemicals were used without further purification.

Cell Culture {#sec4.2}
------------

Human hepatoma HepG2 cells and human glioma U251 cells were cultured in Dulbecco's modified Eagle's medium. All medium contained 10% fetal bovine serum (v/v), 100 μg/mL streptomycin, 100 units/mL penicillin, 1 mM sodium pyruvate, and 1% MEM nonessential amino acids (v/v, Sigma M7145). Cells were maintained at 37 °C in a 5% CO~2~ incubator, and a subculture was performed every 3--4 days.

CLSM Measurements {#sec4.3}
-----------------

HepG2 cells and U251 cells were seeded onto a single-well glass bottom dish at 2.0 × 10^4^ cells/well in a final volume of 100 μL and incubated for ∼24 h at 37 °C, 5% CO~2~. CellLight tubulin--GFP, BacMam 2.0 (Thermo Fisher Scientific) was added to the cells (1 μL per well) and incubated for further 24 h, at 37 °C, 5% CO~2~. After removal of the medium, 10 μM **TP--TMR** in the medium was added to the cells and incubated for a designed period. For evaluation of the effects of MT-binding drugs, 10 μM taxol or 10 μM colchicine was coincubated with 10 μM **TP--TMR** at the same time. For evaluation of the endosomal escape, 0.1 mg/mL FITC--transferrin was coincubated with 10 μM **TP--TMR** at the same time. After washing with PBS, the cells were incubated with 5 μg/mL Hoechst 33342 for 10 min at 37 °C, 5% CO~2~. After washing with PBS, the medium was added to the cells and fluorescence images were acquired. **TP--TMR** was excited with 550 nm and observed through a 574 nm emission band-pass filter (red). Tubulin--GFP was excited with 489 nm and observed through a 510 nm emission band-pass filter (green). FITC--transferrin was excited with 495 nm and observed through a 519 nm emission band-pass filter (green). Hoechst 33342 was excited with 352 nm and observed through a 455 nm emission band-pass filter (cyan).

Cell Viability Assay (WST Assay) {#sec4.4}
--------------------------------

The cultured HepG2 cells were plated in 96-well plates at 1.0 × 10^4^ cells/well in a final volume of 100 μL and incubated for 24 h at 37 °C, 5% CO~2~. The culture medium was replaced with medium containing 0--20 μM **TP--TMR**, taxol, or colchicine and incubated for 24 or 72 h. The culture medium was replaced with fresh medium, and 10 μL of the Cell Counting Kit-8 reaction solution (Dojindo, Japan) was added to each well. After incubation for 4 h, the absorbance at 450 nm was measured. Cell viability (%) was calculated by setting the absorbance of the untreated control cells as 100%.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01089](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01089).Fluorescence spectra of **TP--TMR** and TMR--COOH; CLSM images; cell viability assay ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_001.pdf))Movie S1: Cross-sectional scans of cells acquired at different heights ([MPG](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01089/suppl_file/ao9b01089_si_002.mpg))
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